149 related articles for article (PubMed ID: 26893696)
1. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma.
Ding WZ; Ni QF; Lu YT; Kong LL; Yu JJ; Tan LW; Kong LB
Oncol Lett; 2016 Feb; 11(2):1081-1088. PubMed ID: 26893696
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.
Zhang C; Zhang J
Exp Ther Med; 2018 May; 15(5):4325-4331. PubMed ID: 29725374
[TBL] [Abstract][Full Text] [Related]
3. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
Lv L; Wang X; Ma T
Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
[No Abstract] [Full Text] [Related]
4. MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.
Xiao Y; Tian Q; He J; Huang M; Yang C; Gong L
Onco Targets Ther; 2016; 9():3535-44. PubMed ID: 27366090
[TBL] [Abstract][Full Text] [Related]
5. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
[TBL] [Abstract][Full Text] [Related]
6. MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.
Wang Y; Chen X; Yao N; Gong J; Cao Y; Su X; Feng X; Tao M
J Gastrointest Oncol; 2022 Feb; 13(1):355-367. PubMed ID: 35284123
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.
El Tayebi HM; Waly AA; Assal RA; Hosny KA; Esmat G; Abdelaziz AI
Oncol Lett; 2015 Nov; 10(5):3206-3212. PubMed ID: 26722313
[TBL] [Abstract][Full Text] [Related]
8. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.
Wang W; Zhang H; Tang M; Liu L; Zhou Z; Zhang S; Wang L
Oncol Lett; 2017 May; 13(5):3522-3528. PubMed ID: 28529580
[TBL] [Abstract][Full Text] [Related]
10. miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R.
Hu Y; Yang Z; Bao D; Ni JS; Lou J
Pathol Res Pract; 2019 Dec; 215(12):152674. PubMed ID: 31732382
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
He RQ; Yang X; Liang L; Chen G; Ma J
Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
17. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
19. MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R.
Ren L; Yao Y; Wang Y; Wang S
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31160483
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway.
Ma W; Kang Y; Ning L; Tan J; Wang H; Ying Y
Exp Ther Med; 2017 Oct; 14(4):2853-2862. PubMed ID: 28912847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
